An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial

INTRODUCTION: Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-β 1a) has been used to treat patients with COVID-19. We aimed to compare the effectiveness of high-dose IFN-β 1a compared to low dose IFN-β 1a in severe COVID-19 cases. ME...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int Immunopharmacol
Autores principales: Alavi Darazam, Ilad, Hatami, Firouze, Mahdi Rabiei, Mohammad, Amin Pourhoseingholi, Mohamad, Shabani, Minoosh, Shokouhi, Shervin, Mardani, Masoud, Moradi, Omid, Javandoust Gharehbagh, Farid, Mirtalaee, Nasrinsadat, Negahban, Halimeh, Amirdosara, Mahdi, Zangi, Masoud, Hajiesmaeili, Mohammadreza, Kazempour, Muhanna, Shafigh, Navid
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8238656/
https://ncbi.nlm.nih.gov/pubmed/34224994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2021.107916
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares